Kabra Drugs has received a Letter of Intent (LoI) from the Government of Chhattisgarh for the proposed establishment of a pharmaceutical manufacturing facility at Nava Raipur Pharma Park, Chhattisgarh. The proposed project envisages an investment of around Rs 200 crore and is expected to strengthen the Company's manufacturing capabilities and support its long-term growth strategy. The project is expected to generate around 250 direct and indirect employment opportunities.
The company expects to benefit from applicable state government policies, incentives, approvals, and support mechanisms, subject to sanction orders and compliance with statutory requirements. The investment proposal remains subject to execution of definitive agreements and receipt of necessary approvals and sanctions.
Kabra Drugs is engaged in the business of Permaculture manufacturing and trading in pharma related products.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1877.85 |
| Dr. Reddys Labs. | 1353.25 |
| Cipla | 1443.45 |
| Zydus Lifesciences | 1101.15 |
| Lupin | 2373.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: